华北制药：公司及控股子公司对外担保总额约为16.56亿元

Group 1 - The total external guarantees provided by the company and its subsidiaries amount to approximately 1.656 billion yuan, which represents 30.72% of the audited net assets attributable to ordinary shareholders for the year 2024 [1] - The company has provided guarantees totaling about 1.566 billion yuan for its subsidiaries, accounting for 29.05% of the audited net assets attributable to ordinary shareholders for 2024 [1] - The amount of guarantees for entities outside the consolidated financial statements is 90 million yuan, which is 1.67% of the audited net assets attributable to ordinary shareholders for 2024 [1] Group 2 - For the first half of 2025, the revenue composition of the company is as follows: chemical preparations account for 42.67%, chemical raw materials account for 25.02%, biological preparations account for 16.71%, pharmaceutical and other logistics trade account for 6.76%, and pharmaceutical intermediates account for 6.47% [1] - The current market capitalization of the company is 10.7 billion yuan [1]